Research ArticleCARDIOVASCULAR
Fibrin Affinity of Erythrocyte-Coupled Tissue-Type Plasminogen Activators Endures Hemodynamic Forces and Enhances Fibrinolysis in Vivo
Kumkum Ganguly, Mukul S. Goel, Tatyana Krasik, Khalil Bdeir, Scott L. Diamond, Douglas B. Cines, Vladimir R. Muzykantov and Juan-Carlos Murciano
Journal of Pharmacology and Experimental Therapeutics March 2006, 316 (3) 1130-1136; DOI: https://doi.org/10.1124/jpet.105.093450
Kumkum Ganguly
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Mukul S. Goel
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Tatyana Krasik
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Khalil Bdeir
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Scott L. Diamond
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Douglas B. Cines
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Vladimir R. Muzykantov
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Juan-Carlos Murciano
Institute for Environmental Medicine (K.G., T.K., V.R.M., J.-C.M.), Institute for Medicine and Engineering (M.S.G., S.L.D.), and Departments of Laboratory Medicine (K.B., D.B.C.) and Pharmacology and Institute for Translational Medicine and Therapeutics (V.R.M.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Centro Nacional de Investigaciones Cardiovasculares (J.-C.M.), Madrid, Spain
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
Fibrin Affinity of Erythrocyte-Coupled Tissue-Type Plasminogen Activators Endures Hemodynamic Forces and Enhances Fibrinolysis in Vivo
Kumkum Ganguly, Mukul S. Goel, Tatyana Krasik, Khalil Bdeir, Scott L. Diamond, Douglas B. Cines, Vladimir R. Muzykantov and Juan-Carlos Murciano
Journal of Pharmacology and Experimental Therapeutics March 1, 2006, 316 (3) 1130-1136; DOI: https://doi.org/10.1124/jpet.105.093450
Research ArticleCARDIOVASCULAR
Fibrin Affinity of Erythrocyte-Coupled Tissue-Type Plasminogen Activators Endures Hemodynamic Forces and Enhances Fibrinolysis in Vivo
Kumkum Ganguly, Mukul S. Goel, Tatyana Krasik, Khalil Bdeir, Scott L. Diamond, Douglas B. Cines, Vladimir R. Muzykantov and Juan-Carlos Murciano
Journal of Pharmacology and Experimental Therapeutics March 1, 2006, 316 (3) 1130-1136; DOI: https://doi.org/10.1124/jpet.105.093450
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement